Abstract: EP1078 Type: E-Poster Presentation Session title: Myeloproliferative neoplasms - Clinical Background Navitoclax (Nav) is an oral small-molecule inhibitor of antiapoptotic B-cell lymphoma 2 proteins (BCL-X L, BCL-2, BCL-W) that has shown pronounced antitumor activity in xenograft models.Interim analyses of an ongoing, multicenter, Phase 2 trial (NCT03222609) of Nav plus the Janus ...

Former Presidents. 2019-2021 J Gribben, London, United Kingdom 2017-2019 P Sonneveld, Rotterdam, the Netherlands 2015-2017 AR Green, Cambridge, United Kingdom 2013-2015 C Chomienne, Paris, France 2011-2013 U Jäger, Vienna, Austria 2009-2011 R Foà, Rome, Italy 2007-2009 WE Fibbe, Leiden, the Netherlands 2005-2007 …

Join us for the 30th EHA Congress, taking place in Milan from June 12–15, 2025, as we revolutionize the way we learn and connect in hematology.

Abstract: PB1702 Type: Publication Only Session title: Myeloproliferative neoplasms - Clinical Background Myeloproliferative neoplasm (MPN)-associated myelofibrosis (MF) is a clonal myeloid neoplasm characterized by defective bone marrow (BM) function, BM fibrosis, ineffective erythropoiesis, and increased risk of progression to acute myeloid leukemia (AML).

June 5, 2025 EHA2025 Congress platform opens June 12-15, 2025 EHA2025 Milan, Italy - In-person and live stream Location Allianz MiCo, Milano Convention Centre August 15, 2025 EHA2025 Congress platform closes Scientific Program Committee ...

EHA2025 Congress fees. We offer: Hybrid registration, which means you can take part in person, in Milan, and virtually on the Congress platform—as well as getting access to on-demand content until August 15, 2025; Virtual registration, which means you can enjoy the livestreaming and on-demand access of EHA2025; Please read the EHA2025 Congress registration Terms and conditions, including the ...

Thank you all for joining us in Madrid for the 29th European Hematology Association Congress!The EHA2024 Congress platform is now closed.You may browse selected content through the EHA Library, EHA Open access library.Take a look back at EHA2024 with a br...

EHA is a member of: EMA Healthcare Professionals’ Working Party. Use of EHA name and logo. The use of the name and/or image (logo) of the European Hematology Association (EHA) by partners, such as Specialized Working Groups, National Societies, Patient Organizations and Sponsors is only allowed when the content of the publication is reviewed and approved by EHA.

Abstract: S239 Type: Oral Presentation Session title: Stem cell transplantation - GvHD Background Belumosudil (KD025) is a novel oral selective rho-associated coiled-coil kinase 2 (ROCK2) inhibitor specifically designed for the treatment of cGVHD, an immune-mediated inflammatory and fibrotic disorder.

Accommodation . Welcome to the Hotel Accommodation page for the EHA2025 Congress. Hotel Information and Official Housing Bureau. INTERPLAN AG is the official housing bureau for the EHA2025 Congress.